探讨MG132对人肺腺癌A549细胞凋亡的影响及其机制(3)
 |
| 第1页 |
参见附件(2512KB，3页)。
[6] Adams J, Palombella VJ , Sausville EA, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents [J]. Cancer Research,1999,59:2615-2622.
[7] Wu HJ, Zhang ZG. Ubiquitin-Proteasome pathway and its significance [J]. Journal of International Pathology and Clinical Medicine,2006,26(1):7.
[8] Inoue S, Nakase H, Mat suura M, et al. The effect of proteasome inhibit or MG132 on experimental inflammatory bowel disease [J]. Clinical and Experimental Immunology,2009,156(1):172.
[9] Melikova MS, Kondratov KA, Kornilova ES. Two different stages of epidermal growth factor (EGF) receptor endocytosis are sensitive to free ubiquitin depletion produced by proteasome inhibitor MG 132 [J]. Cell Biol Int,2006,30(1):31-43.
[10] Letoha T, Somlai C, Takacs T, et al. The proteasome inhibitor MG132 protects against acute pancreatitis [J]. Free Radic Biol Med,2005,39 (9):1142-1151.
[11] Pigneux A, Mahon FX, Moreau Gaudry F, et al . Prot easome inhibit ion specifically sensitizes leukemic cel ls to anthracyclin-induced apoptosis through the accumulat ion of Bim and Bax pro-apoptotic proteins [J]. Cancer Biol Ther,2007,6(4):603-611.
[12] Yan XB, Yang DS, Gao X, et al. Caspase- 8 dependent ost eosarcoma cell apoptosis induced by prot easome inhibitor MG132 [J] . Cell Biol Int,2007,31(10):1136-1143.
[13] Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor kappa B is constitutively activated in primitive human acutemye logenous leukemia cells [J]. Blood,2001,98(8):2301-2307.
(收稿日期：2011-06-02)
您现在查看是摘要介绍页，详见PDF附件(2512KB，3页)。